SelectQuote Reports Strong Q2 2026 Earnings Amid Guidance Cuts
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 05 2026
0mins
Should l Buy SLQT?
Source: seekingalpha
- Strong Financial Performance: SelectQuote reported Q2 revenue of $537 million, a 12% year-over-year increase, with the Healthcare Services segment growing 26%, reflecting robust demand and execution in the senior market.
- Record EBITDA Margins: The company achieved a near-record EBITDA margin of 39% in its Senior division, despite facing budget cuts from PBM and carrier partners, indicating strong profitability resilience.
- Credit Facility Expansion: SelectQuote announced a new $415 million credit facility extending debt maturities to 2031, providing greater financial flexibility to support ongoing profitable growth initiatives.
- Revised Financial Guidance: While management remains confident in long-term targets, the fiscal 2026 revenue guidance has been lowered to a range of $1.61 billion to $1.71 billion due to PBM and carrier budget cuts, highlighting short-term market challenges.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SLQT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SLQT
Wall Street analysts forecast SLQT stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.838
Low
5.00
Averages
6.00
High
7.00
Current: 0.838
Low
5.00
Averages
6.00
High
7.00
About SLQT
SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SelectQuote to Release Q3 2026 Financial Results on May 5
- Earnings Release Schedule: SelectQuote will announce its fiscal Q3 2026 financial results before market open on May 5, 2026, which is expected to significantly impact investor sentiment.
- Executive Conference Call: CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 AM ET on the release day to discuss the financial results, enhancing transparency and investor confidence.
- Company Background: Founded in 1985, SelectQuote pioneered the model of providing unbiased comparisons from multiple highly-rated insurance companies, allowing consumers to choose policies that best meet their needs, showcasing its leadership in the insurance sector.
- Business Ecosystem: The company operates three core business lines, including SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life, aimed at addressing the growing Medicare needs of approximately 10,000 seniors turning 65 daily, supporting the healthcare insurance demands of 65 million elderly consumers.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Initiated: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations that could lead to significant legal repercussions for the company.
- False Statements Exposed: According to a federal securities lawsuit, SelectQuote is accused of failing to disclose that its recommendations to Medicare beneficiaries were primarily based on compensation to the company rather than the quality or suitability of the insurance plans.
- Improper Conduct Allegations: SelectQuote is alleged to have failed to provide unbiased comparisons of Medicare Advantage plans and received illegal kickbacks to steer beneficiaries to specific insurers, potentially violating the False Claims Act.
- Increased Compliance Risks: As a result of these actions, SelectQuote may face regulatory and legal sanctions, leading to previous positive statements about the company being deemed misleading and lacking a reasonable basis.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Launched: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations that the company misled investors by failing to disclose its practices regarding Medicare beneficiaries, potentially harming shareholder interests.
- Misconduct Allegations: The lawsuit claims that SelectQuote directed Medicare beneficiaries to insurers that compensated the company best, rather than providing unbiased comparisons, exposing the firm to legal and regulatory sanctions.
- Potential Legal Consequences: SelectQuote's actions may have violated the False Claims Act, leading to risks of regulatory and legal penalties that could adversely affect the company's future operations and reputation.
- Shareholder Rights Protection: Kuehn Law urges shareholders to contact attorneys promptly to protect their rights, emphasizing that shareholder voices are crucial for the integrity and fairness of financial markets.
See More
SelectQuote Faces Delisting Risk as Share Price Falls Below $1
- Delisting Notice: SelectQuote received a notice from the New York Stock Exchange for failing to meet continued listing standards as its average share price fell below $1 for 30 consecutive trading days, indicating poor market performance that could undermine investor confidence.
- Compliance Plan: The company intends to regain compliance within the six-month cure period by lifting its share price, demonstrating its commitment to adhering to market regulations and rebuilding investor trust.
- Trading Continuity: Despite the delisting risk, SelectQuote stated that its stock will continue to trade on the NYSE during the cure period, indicating the company's efforts to maintain market activity and liquidity.
- Future Outlook: SelectQuote is also facing a $40 million financial headwind and has lowered its 2026 guidance, although it targets a 20%+ EBITDA margin and $25–35 million in operating cash flow, reflecting strategic goals amid adversity.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Launched: Kuehn Law, PLLC is investigating whether SelectQuote, Inc. executives breached their fiduciary duties to shareholders, with allegations including failure to disclose the company's direction of Medicare beneficiaries to unsuitable insurance plans, potentially harming shareholder interests.
- Misconduct Allegations: The lawsuit claims that SelectQuote improperly steered Medicare beneficiaries towards certain insurers while receiving illegal kickbacks, indicating serious compliance issues that could expose the company to legal sanctions.
- Increased Compliance Risks: SelectQuote's failure to adhere to applicable laws and regulations may lead to regulatory and legal sanctions, particularly concerning potential violations of the False Claims Act, which could negatively impact the company's reputation and financial health.
- Shareholder Interests at Risk: The executives' actions have resulted in materially misleading positive statements about the company's business prospects, putting shareholders at risk of investment losses, prompting Kuehn Law to urge affected shareholders to contact them promptly to protect their rights.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Initiated: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations including the failure to disclose the company's practice of directing Medicare beneficiaries to unsuitable insurance plans, harming shareholder interests.
- False Statement Allegations: According to a federal securities lawsuit, SelectQuote is accused of failing to provide unbiased comparisons of Medicare Advantage plans and prioritizing its own interests when recommending insurers, potentially facing legal and regulatory sanctions.
- Illegal Kickback Issues: SelectQuote is alleged to have accepted illegal kickbacks to steer Medicare beneficiaries towards specific insurers, thereby limiting enrollment in competitors' plans, which severely impacts the company's compliance and reputation.
- Potential Legal Consequences: Due to these actions, SelectQuote may have violated the False Claims Act, and positive statements regarding the company's operations and prospects are deemed misleading, potentially exposing shareholders to significant financial risks.
See More
SelectQuote to Release Q3 2026 Financial Results on May 5
- Earnings Release Schedule: SelectQuote will announce its fiscal Q3 2026 financial results before market open on May 5, 2026, which is expected to significantly impact investor sentiment.
- Executive Conference Call: CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 AM ET on the release day to discuss the financial results, enhancing transparency and investor confidence.
- Company Background: Founded in 1985, SelectQuote pioneered the model of providing unbiased comparisons from multiple highly-rated insurance companies, allowing consumers to choose policies that best meet their needs, showcasing its leadership in the insurance sector.
- Business Ecosystem: The company operates three core business lines, including SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life, aimed at addressing the growing Medicare needs of approximately 10,000 seniors turning 65 daily, supporting the healthcare insurance demands of 65 million elderly consumers.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Initiated: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations that could lead to significant legal repercussions for the company.
- False Statements Exposed: According to a federal securities lawsuit, SelectQuote is accused of failing to disclose that its recommendations to Medicare beneficiaries were primarily based on compensation to the company rather than the quality or suitability of the insurance plans.
- Improper Conduct Allegations: SelectQuote is alleged to have failed to provide unbiased comparisons of Medicare Advantage plans and received illegal kickbacks to steer beneficiaries to specific insurers, potentially violating the False Claims Act.
- Increased Compliance Risks: As a result of these actions, SelectQuote may face regulatory and legal sanctions, leading to previous positive statements about the company being deemed misleading and lacking a reasonable basis.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Launched: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations that the company misled investors by failing to disclose its practices regarding Medicare beneficiaries, potentially harming shareholder interests.
- Misconduct Allegations: The lawsuit claims that SelectQuote directed Medicare beneficiaries to insurers that compensated the company best, rather than providing unbiased comparisons, exposing the firm to legal and regulatory sanctions.
- Potential Legal Consequences: SelectQuote's actions may have violated the False Claims Act, leading to risks of regulatory and legal penalties that could adversely affect the company's future operations and reputation.
- Shareholder Rights Protection: Kuehn Law urges shareholders to contact attorneys promptly to protect their rights, emphasizing that shareholder voices are crucial for the integrity and fairness of financial markets.
See More
SelectQuote Faces Delisting Risk as Share Price Falls Below $1
- Delisting Notice: SelectQuote received a notice from the New York Stock Exchange for failing to meet continued listing standards as its average share price fell below $1 for 30 consecutive trading days, indicating poor market performance that could undermine investor confidence.
- Compliance Plan: The company intends to regain compliance within the six-month cure period by lifting its share price, demonstrating its commitment to adhering to market regulations and rebuilding investor trust.
- Trading Continuity: Despite the delisting risk, SelectQuote stated that its stock will continue to trade on the NYSE during the cure period, indicating the company's efforts to maintain market activity and liquidity.
- Future Outlook: SelectQuote is also facing a $40 million financial headwind and has lowered its 2026 guidance, although it targets a 20%+ EBITDA margin and $25–35 million in operating cash flow, reflecting strategic goals amid adversity.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Launched: Kuehn Law, PLLC is investigating whether SelectQuote, Inc. executives breached their fiduciary duties to shareholders, with allegations including failure to disclose the company's direction of Medicare beneficiaries to unsuitable insurance plans, potentially harming shareholder interests.
- Misconduct Allegations: The lawsuit claims that SelectQuote improperly steered Medicare beneficiaries towards certain insurers while receiving illegal kickbacks, indicating serious compliance issues that could expose the company to legal sanctions.
- Increased Compliance Risks: SelectQuote's failure to adhere to applicable laws and regulations may lead to regulatory and legal sanctions, particularly concerning potential violations of the False Claims Act, which could negatively impact the company's reputation and financial health.
- Shareholder Interests at Risk: The executives' actions have resulted in materially misleading positive statements about the company's business prospects, putting shareholders at risk of investment losses, prompting Kuehn Law to urge affected shareholders to contact them promptly to protect their rights.
See More
SelectQuote Executives Allegedly Breached Fiduciary Duties
- Legal Investigation Initiated: Kuehn Law, PLLC is investigating whether executives at SelectQuote, Inc. breached their fiduciary duties to shareholders, with allegations including the failure to disclose the company's practice of directing Medicare beneficiaries to unsuitable insurance plans, harming shareholder interests.
- False Statement Allegations: According to a federal securities lawsuit, SelectQuote is accused of failing to provide unbiased comparisons of Medicare Advantage plans and prioritizing its own interests when recommending insurers, potentially facing legal and regulatory sanctions.
- Illegal Kickback Issues: SelectQuote is alleged to have accepted illegal kickbacks to steer Medicare beneficiaries towards specific insurers, thereby limiting enrollment in competitors' plans, which severely impacts the company's compliance and reputation.
- Potential Legal Consequences: Due to these actions, SelectQuote may have violated the False Claims Act, and positive statements regarding the company's operations and prospects are deemed misleading, potentially exposing shareholders to significant financial risks.
See More
